Publication

Byline

Location

Clinical Trial: Y Yoga Works: Effects of Acute Yoga on Anxiety, Affect, & Cognition

U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07816861) titled 'Y Yoga Works: Effects of Acute Yoga on Anxiety, Affect, & Cognition' on Sept. 11, 2025. B... और पढ़ें


Singapore Clinical Trial: Complementary Herbal Approach to Rheumatoid Management Study (CHARMS)

Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'Complementary Herbal Approach to Rheumatoid Management Study (CHARMS)'. The following are the oth... और पढ़ें


Singapore Clinical Trial: 'Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post-operative survival of glaucoma drainage devices'

Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... और पढ़ें


Singapore Clinical Trial: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.

Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... और पढ़ें


Clinical Trial: Pregabalin for Chronic Pelvic Pain in Women

U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07818577) titled 'Pregabalin for Chronic Pelvic Pain in Women' on Sept. 08. Brief Summary: This multicenter... और पढ़ें


Singapore Clinical Trial: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.

Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... और पढ़ें


Singapore Clinical Trial: A Phase 1, Open-Label, Single Dose Study to Investigate the Relative Bioavailability, Safety, and Tolerability of Two Formulations of Eltrekibart in Healthy Participants

Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Open-Label, Single Dose Study to Investigate the Relative Bioavailability, Safety, and... और पढ़ें


Singapore Clinical Trial: ROSETTA HCC-206: An Open-Label, Multi-Center, Randomized Phase 1/2 Study of Pumitamig Alone or In Combination with Ipilimumab in Participants with First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC)

Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'ROSETTA HCC-206: An Open-Label, Multi-Center, Randomized Phase 1/2 Study of Pumitamig Alone or In... और पढ़ें


Singapore Clinical Trial: Phase II Open-label Study Evaluating Ivonescimab in PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma

Singapore, Sept. 15 -- The Health Sciences Authority received information related to the study titled 'Phase II Open-label Study Evaluating Ivonescimab in PD-1 Resistant Recurrent or Metastatic Nasoph... और पढ़ें


Clinical Trial: Value of Optic Nerve Sheath Diameter in Differentiating Ischemic From Hemorrhagic Stroke

U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07818408) titled 'Value of Optic Nerve Sheath Diameter in Differentiating Ischemic From Hemorrhagic Stroke' ... और पढ़ें